*Data is provided by Barchart.com. Data reflects weightings calculated at the beginning of each month. Data is subject to change.
**Green highlights the top performing ETF by % change in the past 100 days.
Company Description (as filed with the SEC)
Akorn, Inc. (“Akorn”, the “Company”) manufactures and markets a full line of
diagnostic and therapeutic ophthalmic pharmaceuticals as well as niche hospital
drugs and injectable pharmaceuticals. In addition, through our subsidiary
Advanced Vision Research, Inc. (“AVR”), we manufacture and market a line of
over-the-counter (“OTC”) ophthalmic products for the treatment of dry eye under
the TheraTears® brand name, as well as a portfolio of private label OTC
ophthalmic products. The Company is a manufacturer and/or marketer of diagnostic
and therapeutic pharmaceutical products in various specialty areas, including
ophthalmology, antidotes, anti-infectives, vaccines, and controlled substances
for pain management and anesthesia, among others. Our customers include
physicians, optometrists, hospitals, wholesalers, group purchasing
organizations, retail pharmacy chains and other pharmaceutical companies. Akorn,
Inc. ... More ...
Please note that once you make your selection, it will apply to all future visits to NASDAQ.com.
If, at any time, you are interested in reverting to our default settings, please select Default Setting above.
If you have any questions or encounter any issues in changing your default settings, please email firstname.lastname@example.org.
Please confirm your selection:
You have selected to change your default setting for the Quote Search. This will now be your default target page;
unless you change your configuration again, or you delete your
cookies. Are you sure you want to change your settings?